Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

US Rheumatoid Arthritis Market and Competitive Landscape 2014-2023 -

Research and Markets
Posted on: 19 Oct 18

The "US Rheumatoid Arthritis Market and Competitive Landscape - 2018" report has been added to's offering.

US Rheumatoid Arthritis Market and Competitive Landscape - 2018, provides comprehensive insights into Rheumatoid Arthritis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Rheumatoid Arthritis market size and drug sales. This research also provides insights into Rheumatoid Arthritis epidemiology and late stage pipeline.

The research is classified into following sections - Rheumatoid Arthritis overview with definitions, symptoms, etiology, diagnosis, treatment options; Rheumatoid Arthritis pipeline insights covering late stage clinical trials pipeline; Rheumatoid Arthritis prevalence trends by countries; Rheumatoid Arthritis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

  • Rheumatoid Arthritis pipeline: Find out the drugs in clinical trials for Rheumatoid Arthritis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Rheumatoid Arthritis epidemiology: Find out the prevalence of Rheumatoid Arthritis in US; prevalence forecast to 2023
  • Rheumatoid Arthritis products: Identify key products marketed and prescribed for Rheumatoid Arthritis by brand name, by molecule, by company, by branded / generic, in US
  • Rheumatoid Arthritis market size: Find out the market size for Rheumatoid Arthritis drugs in US; Find out how the market advanced from 2014
  • Rheumatoid Arthritis drug sales: Find out the sales of Rheumatoid Arthritis drugs in US
  • Rheumatoid Arthritis drugs sales forecast: Sales forecast for Rheumatoid Arthritis drugs to 2023 in US
  • Rheumatoid Arthritis market share analysis: Find out the market shares of Rheumatoid Arthritis drugs and outlook in US

For more information about this report visit

View source version on

Business Wire

Last updated on: 19/10/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.